Company performance
Add to research
Current Price
as of Mar 21, 2025$6.25
P/E Ratio
N/A
Market Cap
$429.55M
Description
Add to research
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Metrics
Add to research
Overview
- HQWatertown, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerEYPT
- Price$6.25+2.46%
Trading Information
- Market cap$429.55M
- Float86.75%
- Average Daily Volume (1m)792,195
- Average Daily Volume (3m)809,274
- EPS-$2.32
Company
- Revenue$43.27M
- Rev growth (1yr)-5.97%
- Net income-$130.87M
- Gross margin91.42%
- EBITDA margin-333.50%
- EBITDA-$144.31M
- EV$71.61M
- EV/Revenue1.65
- P/EN/A
- P/S8.13
- P/B1.27
- Debt/Equity6.87
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account